BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33021557)

  • 1. Loss of X Chromosome Inactivation in Androgenetic Complete Hydatidiform Moles With 46, XX Karyotype.
    Chen X; Ma Y; Wang L; Zhang X; Yu Y; Lü W; Xie X; Cheng X
    Int J Gynecol Pathol; 2021 Jul; 40(4):333-341. PubMed ID: 33021557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgenetic Complete Hydatidiform Moles With p57KIP2-Positive Immunostaining.
    Usui H; Sato A; Ota M; Ikeda JI; Shozu M
    Am J Clin Pathol; 2020 Nov; 154(6):776-783. PubMed ID: 32686837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental contribution to trisomy in heterozygous androgenetic complete moles.
    Usui H; Sato A; Shozu M
    Sci Rep; 2020 Oct; 10(1):17137. PubMed ID: 33051545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.
    Xing D; Adams E; Huang J; Ronnett BM
    Mod Pathol; 2021 May; 34(5):961-982. PubMed ID: 33024305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Complete Hydatidiform Moles: Analysis of a Case Series With Genotyping.
    Bynum J; Murphy KM; DeScipio C; Beierl K; Adams E; Anderson D; Vang R; Ronnett BM
    Int J Gynecol Pathol; 2016 Mar; 35(2):134-41. PubMed ID: 26535984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
    Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
    Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Androgenetic Complete Hydatidiform Moles with p57
    Li MW; Li F; Cheng J; Wang F; Zhou P
    Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
    McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
    Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choriocarcinoma in Women: Analysis of a Case Series With Genotyping.
    Savage J; Adams E; Veras E; Murphy KM; Ronnett BM
    Am J Surg Pathol; 2017 Dec; 41(12):1593-1606. PubMed ID: 28877059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-aneuploidy in 46,XX hydatidiform moles.
    Vejerslev LO; Larsen JK; Christensen IJ; Tommerup N
    Cancer Genet Cytogenet; 1987 Aug; 27(2):225-8. PubMed ID: 3594413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases.
    Gaillot-Durand L; Patrier S; Aziza J; Devisme L; Riera AC; Marcorelles P; Pelluard F; Gasser B; Mauduit C; Hajri T; Massardier J; Bolze PA; Golfier F; Devouassoux-Shisheboran M; Allias F
    Hum Pathol; 2020 Jul; 101():18-30. PubMed ID: 32387104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic studies of hydatidiform mole with 46,XY karyotype (author's transl)].
    Ohama K; Okamoto E; Nomura K; Fujiwara A; Fukuda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1664-8. PubMed ID: 6458639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic studies in hydatidiform mole with clinical correlations.
    Lawler SD; Fisher RA
    Placenta; 1987; 8(1):77-88. PubMed ID: 3473466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete hydatidiform moles are composed of paternal chromosomes and maternal mitochondria.
    Pan Z; Usui H; Sato A; Shozu M
    Mitochondrial DNA A DNA Mapp Seq Anal; 2018 Aug; 29(6):943-950. PubMed ID: 29037102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydatidiform moles: ancillary techniques to refine diagnosis.
    Ronnett BM; DeScipio C; Murphy KM
    Int J Gynecol Pathol; 2011 Mar; 30(2):101-16. PubMed ID: 21293291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auxiliary and experimental diagnostic techniques for hydatidiform moles.
    Usui H
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3077-3086. PubMed ID: 36098274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation profiles of imprinted genes are distinct between mature ovarian teratoma, complete hydatidiform mole, and extragonadal mature teratoma.
    Kato N; Kamataki A; Kurotaki H
    Mod Pathol; 2021 Feb; 34(2):502-507. PubMed ID: 32873866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
    Wake N; Arima T; Matsuda T
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-8. PubMed ID: 9833609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twin/Multiple Gestations With a Hydatidiform Mole: Clinicopathologic Analysis of 21 Cases With Emphasis on Molecular Genotyping and Parental Contribution.
    Xing D; Adams E; Zou YS; Morsberger L; Scanga LR; Gao FF; Barker N; Vang R; Ronnett BM
    Am J Surg Pathol; 2022 Sep; 46(9):1180-1195. PubMed ID: 35796652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.
    Lai CY; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Tsao SW; Cheung AN
    Mod Pathol; 2004 Jan; 17(1):40-8. PubMed ID: 14631372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.